is glp 1 safe during breastfeeding Can you take GLP-1 while breastfeeding? What the research actually shows Is semaglutide use during breastfeeding

Additionally, long-acting liraglutide and ultralong-acting semaglutide can mitigate the risk of adverse cardiovascular events in T2DM patients, whereas exenatide has no substantial effect on the incidence of adverse cardiovascular events (60)

Major events from the past few years, including the approval of several high-potency GLP-1 drugs in 2021 and 2022, have catalyzed this growth trajectory

Over 100 million people in the US are obese, according to the US Centers for Disease Control and Prevention

This claim appears to have emerged from anecdotal reports on social media and online forums, but it is not supported by clinical trials, peer-reviewed research, or regulatory documentation from the MHRA, European Medicines Agency (EMA), or manufacturer's prescribing information

Tirzepatide in obesitythe surmount clinical study program The GLP-1RA liraglutide has been approved for the pharmacological treatment of obesity and various other GLP-1RA may be approved in the future for this indication as well (3941, 81)

Lopez PD, Bhatia K, Bohra C, et al